| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0027 | 0.9 |